Redsense Medical AB (publ)

NGM:REDS Stock Report

Market Cap: kr111.2m

Redsense Medical Past Earnings Performance

Past criteria checks 0/6

Redsense Medical's earnings have been declining at an average annual rate of -4.6%, while the Medical Equipment industry saw earnings growing at 5% annually. Revenues have been growing at an average rate of 14.4% per year.

Key information

-4.6%

Earnings growth rate

0.3%

EPS growth rate

Medical Equipment Industry Growth6.2%
Revenue growth rate14.4%
Return on equity-19.5%
Net Margin-17.7%
Next Earnings Update08 May 2024

Recent past performance updates

Recent updates

Here's Why We're Watching Redsense Medical's (NGM:REDS) Cash Burn Situation

Jun 15
Here's Why We're Watching Redsense Medical's (NGM:REDS) Cash Burn Situation

Redsense Medical (NGM:REDS) Is In A Good Position To Deliver On Growth Plans

Mar 01
Redsense Medical (NGM:REDS) Is In A Good Position To Deliver On Growth Plans

We're Not Very Worried About Redsense Medical's (NGM:REDS) Cash Burn Rate

Nov 10
We're Not Very Worried About Redsense Medical's (NGM:REDS) Cash Burn Rate

Is Redsense Medical (NGM:REDS) In A Good Position To Deliver On Growth Plans?

Apr 20
Is Redsense Medical (NGM:REDS) In A Good Position To Deliver On Growth Plans?

Shareholders Are Thrilled That The Redsense Medical (NGM:REDS) Share Price Increased 236%

Feb 24
Shareholders Are Thrilled That The Redsense Medical (NGM:REDS) Share Price Increased 236%

Revenue & Expenses Breakdown
Beta

How Redsense Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NGM:REDS Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2326-5180
30 Sep 2326-6200
30 Jun 2322-8210
31 Mar 2319-7220
31 Dec 2217-9220
30 Sep 2213-7220
30 Jun 2219-7240
31 Mar 2216-8210
31 Dec 2116-8230
30 Sep 2115-13230
30 Jun 2111-14200
31 Mar 2117-11210
31 Dec 2017-9170
30 Sep 2018-5140
30 Jun 2020-2140
31 Mar 2017-4130
31 Dec 1914-5130
30 Sep 1912-6110
30 Jun 1911-6110
31 Mar 199-6110
31 Dec 189-7110
30 Sep 187-7110
30 Jun 184-8110
31 Mar 184-8100
31 Dec 172-990
30 Sep 174-890
30 Jun 175-7100
31 Mar 175-690
31 Dec 166-580
30 Sep 164-570
30 Jun 162-550
31 Mar 162-450
31 Dec 152-340
30 Sep 152-340
30 Jun 153-340
31 Mar 152-330
31 Dec 142-230
31 Dec 132-340

Quality Earnings: REDS is currently unprofitable.

Growing Profit Margin: REDS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: REDS is unprofitable, and losses have increased over the past 5 years at a rate of 4.6% per year.

Accelerating Growth: Unable to compare REDS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: REDS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (25.4%).


Return on Equity

High ROE: REDS has a negative Return on Equity (-19.54%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.